Biora Therapeutics (BIOR)

Biora Therapeutics (BIOR) Stock Price & Analysis


BIOR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.95 - $28.75
Previous Close$4.48
Average Volume (3M)147.64K
Market Cap
Enterprise Value$152.01M
Total Cash (Recent Filing)$30.50M
Total Debt (Recent Filing)$128.20M
Price to Earnings (P/E)-1.0
Aug 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.66
Shares Outstanding11,859,095
10 Day Avg. Volume384,084
30 Day Avg. Volume147,636
Standard Deviation0.37
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)27157.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue760.07
Enterprise Value/Gross Profit498.41
Enterprise Value/Ebitda-4.05
Price Target Upside1350.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Biora Therapeutics’s price range in the past 12 months?
Biora Therapeutics lowest stock price was $1.95 and its highest was $28.75 in the past 12 months.
    What is Biora Therapeutics’s market cap?
    Currently, no data Available
    When is Biora Therapeutics’s upcoming earnings report date?
    Biora Therapeutics’s upcoming earnings report date is Aug 16, 2023 which is in 76 days.
      How were Biora Therapeutics’s earnings last quarter?
      Biora Therapeutics released its earnings results on May 15, 2023. The company reported -$1.59 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.59.
        Is Biora Therapeutics overvalued?
        According to Wall Street analysts Biora Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Biora Therapeutics pay dividends?
          Biora Therapeutics does not currently pay dividends.
          What is Biora Therapeutics’s EPS estimate?
          Biora Therapeutics’s EPS estimate is -$1.6.
            How many shares outstanding does Biora Therapeutics have?
            Biora Therapeutics has 11,859,095 shares outstanding.
              What happened to Biora Therapeutics’s price movement after its last earnings report?
              Biora Therapeutics reported an EPS of -$1.59 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.388%.
                Which hedge fund is a major shareholder of Biora Therapeutics?
                Among the largest hedge funds holding Biora Therapeutics’s share is Driehaus Capital Management LLC. It holds Biora Therapeutics’s shares valued at N/A.


                  Biora Therapeutics Stock Smart Score

                  The Biora Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Biora Therapeutics

                  Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.


                  Top 5 ETFs holding BIOR

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold BIOR. The ETFs are listed according to market value of BIOR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bioxcel Therapeutics
                  Cyclacel Pharmaceuticals
                  Fate Therapeutics
                  G1 Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis